Author:
Freeman Meagan,Fakhori Nina,Monteil Danielle
Abstract
We present an infant referred to Developmental Paediatrics for delays, slow growth, hypotonia, esotropia and spasticity. Over the course of 2 months, the infant’s exam progressed, demonstrating worsening spasticity and tonal changes in the setting of a normal brain MRI with acquired microcephaly. Genetic testing demonstrated a pathogenicCTNNB1nonsense mutation. Following the discovery of the underlying cause for the child’s clinical picture, the child was evaluated by therapeutic services and neurology, which was initially only available via asynchronous telehealth, due to a resource limited area. Cerebral palsy is a nonprogressive neurodevelopmental disorder and, when associated with developmental delay, qualifies for further genetic investigation into the underlying aetiology. Genetic testing recommendations exist for developmental delay, but there is no current algorithm regarding testing for cerebral palsy. Education and clear guidelines on genetic testing allow for better prognostication and potential treatment in cases of cerebral palsy, especially when associated with other disorders.
Reference14 articles.
1. Centers for Disease Control and Prevention . Cerebral palsy. 2024. Available: https://www.cdc.gov/ncbddd/cp/facts.html
2. Ho SKL , Tsang MHY , Lee M , et al . CTNNB1 neurodevelopmental disorder. In: GeneReviews. 2022.
3. CTNNB1 in neurodevelopmental disorders;Zhuang;Front Psychiatry,2023
4. "CTNNB1 gene," medlineplu. Bethesda (MD) National Library of Medicine (US); 2018. Available: https://medlineplus.gov/genetics/gene/ctnnb1/#resources [accessed 14 May 2024]
5. Dominant β-catenin mutations cause intellectual disability with recognizable syndromic features